| Interferon-gamma–producing CD8+ tissue resident memory T cells are a targetable hallmark of immune checkpoint inhibitor–colitis SC Sasson, SM Slevin, VTF Cheung, I Nassiri, A Olsson-Brown, E Fryer, ... Gastroenterology 161 (4), 1229-1244. e9, 2021 | 134 | 2021 |
| New insights into the mechanisms of action of anti–tumor necrosis factor-α monoclonal antibodies in inflammatory bowel disease SM Slevin, LJ Egan Inflammatory bowel diseases 21 (12), 2909-2920, 2015 | 66 | 2015 |
| Lymphocyte activation gene (LAG)-3 is associated with mucosal inflammation and disease activity in ulcerative colitis SM Slevin, LC Garner, C Lahiff, M Tan, LM Wang, H Ferry, B Greenaway, ... Journal of Crohn's and Colitis 14 (10), 1446-1461, 2020 | 39 | 2020 |
| Phenotypic and functional heterogeneity of human intermediate monocytes based on HLA‐DR expression EP Connaughton, S Naicker, SA Hanley, SM Slevin, JK Eykelenboom, ... Immunology and Cell Biology 96 (7), 742-758, 2018 | 31 | 2018 |
| Infliximab selectively modulates the circulating blood monocyte repertoire in crohn's disease SM Slevin, MC Dennedy, EP Connaughton, A Ribeiro, R Ceredig, ... Inflammatory Bowel Diseases 22 (12), 2863-2878, 2016 | 11 | 2016 |
| Activation of MAIT cells plays a critical role in viral vector vaccine immunogenicity NM Provine, A Amini, LC Garner, C Dold, C Hutchings, MEB FitzPatrick, ... bioRxiv, 661397, 2019 | 7 | 2019 |
| Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis T Gupta, A Antanaviciute, CHJ Lee, RO Babu, A Aulicino, Z Christoforidou, ... Cancer Cell 42 (5), 797-814. e15, 2024 | 6 | 2024 |
| Clinical and translational outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease receiving vedolizumab KD Williamson, S Slevin, C Willberg, R Chapman, P Klenerman, ... Journal of Hepatology 1 (66), S544-S545, 2017 | 4 | 2017 |
| Intestinal expression of LAG-3 correlates with inflammatory activity and response to biological therapy in ulcerative colitis S Slevin, M Tan, C Lahiff, K Williamson, A Geremia, S Hughes, K Leavens, ... JOURNAL OF CROHNS & COLITIS 12, S125-S125, 2018 | 3 | 2018 |
| P93 Faecal microbiota transplant for refractory checkpoint inhibitor immunotherapy-related colitis V Cheung, S Sasson, M Misheva, S Slevin, T Gupta, G Webb, A Walsh, ... Gut 70 (Suppl 1), A89-A89, 2021 | 2 | 2021 |
| DOP11 Lymphocyte activation gene (LAG)-3 on T cells is a potential therapeutic target in ulcerative colitis S Slevin, M Tan, C Lahiff, LM Wang, B Greenaway, K Lynch, A Geremia, ... Journal of Crohn's and Colitis 13 (Supplement_1), S033-S033, 2019 | 1 | 2019 |
| Mo1878–Lymphocyte Activation Gene (LAG)-3 on T Cells is a Potential Therapeutic Target in Ulcerative Colitis S Slevin, M Tan, C Lahiff, LM Wang, B Greenaway, KD Lynch, A Geremia, ... Gastroenterology 156 (6), S-872-S-873, 2019 | | 2019 |
| Anti-TNFalpha therapy is associated with rapid reduction of circulating monocyte numbers and blunted monocyte pro-inflammatory response in patients with Crohn’s disease S Slevin, C Dennedy, A Ribeiro, R Ceredig, M Griffin, L Egan JOURNAL OF CROHNS & COLITIS 10, S264-S265, 2016 | | 2016 |
| The effects of anti-TNF antibody therapy on peripheral blood S Slevin Apoptosis 68 (77), 82-83, 2015 | | 2015 |
| The effects of anti-TNFα antibody therapy on peripheral blood mononuclear cells in patients with inflammatory bowel disease S Slevin National University of Ireland–Galway, 2015 | | 2015 |
| Phenotypic and functional heterogeneity of intermediate monocytes in healthy adults. E Connaughton | | 2015 |
| P084 Effect of infliximab on monocyte subtypes in blood of patients with chronic inflammatory bowel disease S Slevin, C Dennedy, M Griffin, L Egan Journal of Crohn's and Colitis, S43, 2013 | | 2013 |
| Circulating Human Monocytes differ in Phenotype and Function According to Metabolic Profile in Obesity and Type 2 Diabetes Mellitus MC Dennedy, SP Lopez, S Hanley, E Connaughton, S Slevin, R Ceredig, ... IRISH JOURNAL OF MEDICAL SCIENCE 181, S344-S345, 2012 | | 2012 |
